Speciality glass and ceramics maker Corning is developing a new high-volume glass manufacturing facility in Durham County, North Carolina, US.

Corning originally announced plans for the new glass manufacturing plant in July 2017.

The company is set to invest $189m in the new facility, which will primarily be used to produce its Valor® pharmaceutical glass packaging containers.

The Durham facility is anticipated to create 300 new jobs in the US and is scheduled to be operational by the end of 2019.

Corning Valor glass manufacturing facility background

The new manufacturing facility forms part of a $4bn pharmaceutical glass packaging initiative involving Corning, Merck and Pfizer.

The three companies intend to drive modernisation and innovation in pharmaceutical glass packaging technology and generate 4,000 new jobs as part of the development.

Phase one of the initiative includes an investment of $500m in Corning’s facilities in order to expand the production of Valor glass and create 1,000 new employment opportunities.

“The company is set to invest $189m in the new facility, which will primarily be used to produce its Valor pharmaceutical glass packaging containers.”

Corning previously announced the expansion its Corning Innovation Support Center (CISC) in Big Flats, New York, and its Research and Development Facility in Erwin, New York, in support of the project.

It is also expected to expand its existing production plant in Vineland, New Jersey, as well as another facility in the south-eastern part of the US.

The initiative is slated to enable the domestic production of glass in the US, as 98% of all glass used in the country is currently carried out overseas.

Details of the new high-volume glass manufacturing facility

The new packaging plant is proposed to be built alongside the Corning Life Sciences manufacturing facility.

It will manufacture Corning’s Valor pharmaceutical glass packaging containers, which are designed to protect, store and deliver the latest drugs and medicines.

The new product was developed based on drug formulation and manufacturing insights provided by Merck and Pfizer.

Combined with Corning’s glass technology and precision capabilities, the Valor glass solution was specifically developed for injectable drugs stored in vials and cartridges.

The new facility is expected to allow Corning to further improve its Valor glass solution.

Valor glass features and benefits

The glass container features a chemically durable drug contacting surface, which eliminates delamination.

It has a uniform interior surface and lesser extractable concentrations, making it ideal for application with drug products.

In addition, Valor glass containers are also crack-proof, resistant to damage and breakage, and able to reduce glass particulate generation.

Further, they are capable of withstanding extreme incidents during drug processing and field applications.

Valor glass containers also result in fewer glass-related interventions and provide high levels of protection for drugs when handled by the consumer.

The containers’ resistance to cracks and damage enables smoother filling operations and allow filling lines to be operated at higher speeds, thereby improving production and providing reliable access to drugs for patients worldwide.

Marketing commentary on Corning

Headquartered in New York, US, Corning is one of the leading innovators in materials science and has been known for developing pioneering inventions for 167 years.

The company possesses expertise in the fields of glass science, ceramics science and optical physics.

Corning’s businesses are spread across the optical communications, mobile electronics, display technology and life science vessels markets.

Products manufactured by the company include protective cover glass for mobile devices, innovative display precision glass, optical fibres, and drug discovery and delivery products, in addition to clean-air technologies for cars and trucks.

The company employs a total of 45,000 personnel globally and generated sales worth $10.5bn in 2017.